Cerner announced Aug. 20 the purchase of privately held Image Devices, a PACS developer based near Frankfurt, Germany. The acquisition will promote the continued development and enhancement of Cerner's PACS, while substantially increasing the Kansas
Cerner announced Aug. 20 the purchase of privately held Image Devices, a PACS developer based near Frankfurt, Germany. The acquisition will promote the continued development and enhancement of Cerner's PACS, while substantially increasing the Kansas City, MO, company's presence in Europe. It is expected to be nondilutive in 2002 and slightly accretive in 2003. Most of Image Devices' more than 80 European PACS installations are in Germany, Switzerland, and Austria. Additionally, its image archives are installed in more than 30 U.S. hospitals. Image Devices has been working with Cerner since 1999, developing and supplying image archive components for Cerner's ProVision PACS. The archive is a key element of Cerner's Open Image Foundation, which provides enterprise-wide image storage, according to Cerner. From now on, Image Devices will be known as "Image Devices, a Cerner company." Its PACS technology will be sold under the Cerner ProVision PACS brand name globally. All Image Devices staff will be retained and will remain located in the Aachen and Idstein, Germany, offices, according to Cerner.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.